#Commn Pathways 318 Cell Line.     

MYC TARGETS V1,     
COAGULATION,     
E2F TARGETS,     
KRAS SIGNALING UP,     
EPITHELIAL MESENCHYMAL TRANSITION,     
HYPOXIA,     
ESTROGEN RESPONSE EARLY,     
INFLAMMATORY RESPONSE,     
COMPLEMENT,     
APICAL JUNCTION,     
ALLOGRAFT REJECTION,     
ANGIOGENESIS